(R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3yloxy)methyl)piperidin-1yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors

Details for Australian Patent Application No. 2011216950 (hide)

Owner Pfizer Inc.

Inventors Noguchi, Hirohide; Waizumi, Nobuaki

Agent Shelston IP

Pub. Number AU-A-2011216950

PCT Pub. Number WO2011/101774

Priority 61/304,921 16.02.10 US

Filing date 9 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/423 - condensed with carbocyclic rings

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/101774 Priority application(s): WO2011/101774

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011216964-Process for producing electrically conductive bonds between solar cells

2011216901-Method for determining the position of plant components in mining extracting plants